# Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)

> **NCT05279651** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Jagiellonian University** · enrollment: 2146 (actual)

## Conditions studied

- Myocardial Injury After Noncardiac Surgery (MINS)
- Myocardial Ischemia

## Interventions

- **DRUG:** Ivabradine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05279651
- **Lead sponsor:** Jagiellonian University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-13
- **Primary completion:** 2025-04-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 2146 (ACTUAL)
- **Last updated:** 2025-09-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05279651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05279651, "Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05279651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*